Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion
- Hyun Young Kim, K. Kim, Myungyeon Kim, H. Kim, Kwang Youl Lee, K. Kang
- Biology, MedicineOxidative Medicine and Cellular Longevity
- 22 April 2019
Data strongly support the use of auranofin for the prevention of osteoclast-related osteoporosis.